HLA ‐B Leader Dimorphism Predicts BK Polyomavirus Replication After Kidney Transplant
HLA · 2025-11 · 106 (5)
DOI: 10.1111/tan.70477 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 20.11.2025. Verfasst von Aurélien Aubry und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Amiens University Hospital, Amiens, France. Hauptthemen laut MEDLINE: Kidney Transplantation, BK Virus, Virus Replication, Polyomavirus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BK polyomavirus (BKPyV) and Cytomegalovirus (CMV) often replicate after kidney transplantation, with management limited to reducing immunosuppression and risking rejection. Among genetic factors that may modulate the antiviral response, HLA evolutionary divergence (HED, allowing a greater diversity of antigen presentation) and the HLA‐B leader dimorphism (MM, MT, TT, influencing NK cell–mediated immunity) are interesting. We aimed to compare these parameters between patients who experienced viral replication within the first post‐transplant year and those who did not. We analysed 306 kidney transplants performed between 2019 and 2023 at Amiens University Hospital. HLA typing was performed in recipients and donors to determine HED (loci A, B, C, DRB1, DQB1) and HLA‐B leader dimorphism. 22.5% of the recipients (69/306) developed BKPyV possible nephropathy (defined by urinary PCR > 7 log 10 copies/mL or DNAemia) and 40.2% (123/306) developed CMV infection during the first year. In a multivariate analysis, a donor–recipient HLA‐B leader mismatch was protective against BKPyV replication (OR = 0.48; p = 0.02), whereas no similar association was observed for CMV replication (OR = 1.42; p = 0.169). HLA‐B leader dimorphism could serve as a predictor of BKPyV replication risk, if confirmed in independent cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Virology, Amiens University Hospital, Amiens, France.
- UR 4294, Agents Infectieux, Résistance et Chimiothérapie (AGIR), Jules Verne University of Picardie, Amiens, France.
- Department of Nephrology Dialysis Transplantation, Amiens University Hospital, Amiens, France.
- Department of Histocompatibility, Amiens University Hospital, Amiens, France.
- EA4666 HEMATIM, Jules Verne University of Picardie, Amiens, France.
ORCID-Profile: Nicolas Guillaume
Zitieren
APA
Aubry, A., Demey, B., Helle, F., Fourdinier, O., Lion, J., Desoutter, J., Brochot, E., & Guillaume, N. (2025). HLA ‐B Leader Dimorphism Predicts BK Polyomavirus Replication After Kidney Transplant. HLA, 106(5). https://doi.org/10.1111/tan.70477
Vancouver
Aubry A, Demey B, Helle F, Fourdinier O, Lion J, Desoutter J, et al. HLA ‐B Leader Dimorphism Predicts BK Polyomavirus Replication After Kidney Transplant. HLA. 2025;106(5). doi:10.1111/tan.70477
BibTeX
@article{Aubry2025,
author = {Aubry, Aurélien and Demey, Baptiste and Helle, François and Fourdinier, Ophélie and Lion, Julien and Desoutter, Judith and Brochot, Etienne and Guillaume, Nicolas},
title = {HLA ‐B Leader Dimorphism Predicts BK Polyomavirus Replication After Kidney Transplant},
journal = {HLA},
year = {2025},
volume = {106},
number = {5},
doi = {10.1111/tan.70477}
}
EUVIMED